Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Informatics Software Application Challenges Researchers to "Ask for Knowledge from Data”

By LabMedica International staff writers
Posted on 16 Sep 2009
New data integration and knowledge software can be applied to visualizing and confirming data-driven hypotheses.

IO Informatics, Inc. More...
(Berkeley, CA, USA), a provider of semantically-enabled life science/healthcare data integration and knowledge software, revealed its new innovative knowledge application, Applied Semantic Knowledgebase (ASK), during a presentation at the recent GTCBio "Rediscovering Biomarkers” Conference, held in San Diego, CA, USA, in August 2009.

Bob Stanley, IO Informatics president and CEO, told the conference attendees, "ASK allows you to move beyond traditional data capture and integration to realize practical value from the knowledge contained in your data. It provides a collection of specific models, built directly from your research, which can be applied to visualizing and validating data-driven hypotheses, as well as for knowledge-based screening and decision-making. ASK gives you a decisive competitive advantage in many areas, such as biomarker-based predictive biology and personalized medicine, including, but not limited to, target profile creation and validation, compound efficacy and promiscuity screening, toxicity profiling and detection, disease signature detection, predictive clinical trials pre-screening, and patient stratification.”

Mr. Stanley went on to clarify how ASK is delivered via the Sentient software suite and is a combination of three of its core technologies: the Sentient software framework for data access and integration; state-of-the-art Semantic methods and applications; and innovative SPARQL array tools. The combination of these technologic capabilities provides researchers with the ability to capture, access, organize, and apply the knowledge contained in their data, in order to solve critical scientific and business challenges.

"Our goal as your partners in discovery,” Mr. Stanley explained, "is to apply our experience and expertise in both software and informatics methods relating to your specific research interests, so that you can obtain and apply the answers you need to solve your complex scientific and related business questions.”

Building on its advanced data access and integration capabilities, Sentient applies semantic patterns to create predictive network models using virtually any combination of internal experimental data and/or external published information. These patterns apply semantic SPARQL query technology to build complex searches across multiple information sets. SPARQL is a new type of semantic search technology capable of detecting patterns within and between different data types and relationships, even if the initial datasets are not formally joined under any common database schema or data federation method.

These patterns or models are then placed in an ASK which is unique to the scientists research focus. The researcher is then able to exploit the knowledge contained within the ASK, by querying the models themselves or by additionally creating new datasets for deeper investigation and analysis. "This transformational technology,” concluded Mr. Stanley, "makes it possible to actively leverage previously disconnected data--creating valuable knowledge that can be used to deliver a revolutionary set of applications for the life-science industry and personalized medicine.”

IOI develops software for data integration and knowledge applications. Its Semantically-enabled Sentient software suite allows life science, biotechnology, pharmaceutical, and medical researchers to structure and define complex data relationships across data sources, view these relationships, query them, and capitalize on them--all within a secure, compliant, auditable framework that helps organizations accumulate and utilize knowledge.

Related Links:

IO Informatics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.